Cargando…
Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance: Abrogation Prevents Tumor Recurrence
Our previous work demonstrated that cytotoxic T lymphocyte (CTL)-mediated tumor immunosurveillance of the 15-12RM tumor could be suppressed by a CD1d-restricted lymphocyte, most likely a natural killer (NK) T cell, which produces interleukin (IL)-13. Here we present evidence for the effector element...
Autores principales: | Terabe, Masaki, Matsui, So, Park, Jong-Myun, Mamura, Mizuko, Noben-Trauth, Nancy, Donaldson, Debra D., Chen, Wanjun, Wahl, Sharon M., Ledbetter, Steven, Pratt, Bruce, Letterio, John J., Paul, William E., Berzofsky, Jay A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194133/ https://www.ncbi.nlm.nih.gov/pubmed/14657224 http://dx.doi.org/10.1084/jem.20022227 |
Ejemplares similares
-
Regulation of Tumor Immune Surveillance and Tumor Immune Subversion by TGF-β
por: Park, Hae-Young, et al.
Publicado: (2009) -
Tumor immunosurveillance in human cancers
por: Mlecnik, Bernhard, et al.
Publicado: (2011) -
TYK2 in Tumor Immunosurveillance
por: Karjalainen, Anzhelika, et al.
Publicado: (2020) -
A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance
por: Terabe, Masaki, et al.
Publicado: (2005) -
Tissue-Specific Roles of NKT Cells in Tumor Immunity
por: Terabe, Masaki, et al.
Publicado: (2018)